JP2018058869A - ハロゲン化環式化合物の合成方法 - Google Patents
ハロゲン化環式化合物の合成方法 Download PDFInfo
- Publication number
- JP2018058869A JP2018058869A JP2017225725A JP2017225725A JP2018058869A JP 2018058869 A JP2018058869 A JP 2018058869A JP 2017225725 A JP2017225725 A JP 2017225725A JP 2017225725 A JP2017225725 A JP 2017225725A JP 2018058869 A JP2018058869 A JP 2018058869A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- group
- alkyl group
- addition product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 150000001923 cyclic compounds Chemical class 0.000 title claims abstract description 14
- 230000002194 synthesizing effect Effects 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 45
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 9
- 150000004820 halides Chemical class 0.000 claims abstract description 9
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 125000005647 linker group Chemical group 0.000 claims abstract description 7
- 125000004429 atom Chemical group 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000000460 chlorine Chemical group 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Chemical group 0.000 claims description 7
- 239000012043 crude product Substances 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 125000001153 fluoro group Chemical group F* 0.000 claims description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 238000007259 addition reaction Methods 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000012429 reaction media Substances 0.000 claims description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- CGJMROBVSBIBKP-UHFFFAOYSA-N malonamic acid Chemical compound NC(=O)CC(O)=O CGJMROBVSBIBKP-UHFFFAOYSA-N 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000007858 starting material Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 125000005843 halogen group Chemical group 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 9
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 9
- WCEBFEVZTGLOHC-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-pyrimidin-2-one Chemical compound OC1=NC=CC(C(F)(F)F)=N1 WCEBFEVZTGLOHC-UHFFFAOYSA-N 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- PNQBEPDZQUOCNY-UHFFFAOYSA-N trifluoroacetyl chloride Chemical compound FC(F)(F)C(Cl)=O PNQBEPDZQUOCNY-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PYXNITNKYBLBMW-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrazole Chemical compound FC(F)(F)C1=CC=NN1 PYXNITNKYBLBMW-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- YKYIFUROKBDHCY-ONEGZZNKSA-N (e)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical compound CCO\C=C\C(=O)C(F)(F)F YKYIFUROKBDHCY-ONEGZZNKSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910000039 hydrogen halide Inorganic materials 0.000 description 4
- 239000012433 hydrogen halide Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- SCZNXLWKYFICFV-UHFFFAOYSA-N 1,2,3,4,5,7,8,9-octahydropyrido[1,2-b]diazepine Chemical compound C1CCCNN2CCCC=C21 SCZNXLWKYFICFV-UHFFFAOYSA-N 0.000 description 2
- PPNCOQHHSGMKGI-UHFFFAOYSA-N 1-cyclononyldiazonane Chemical compound C1CCCCCCCC1N1NCCCCCCC1 PPNCOQHHSGMKGI-UHFFFAOYSA-N 0.000 description 2
- ZPTRYWVRCNOTAS-UHFFFAOYSA-M 1-ethyl-3-methylimidazol-3-ium;trifluoromethanesulfonate Chemical compound CC[N+]=1C=CN(C)C=1.[O-]S(=O)(=O)C(F)(F)F ZPTRYWVRCNOTAS-UHFFFAOYSA-M 0.000 description 2
- OHMHBGPWCHTMQE-UHFFFAOYSA-N 2,2-dichloro-1,1,1-trifluoroethane Chemical compound FC(F)(F)C(Cl)Cl OHMHBGPWCHTMQE-UHFFFAOYSA-N 0.000 description 2
- JPTLLABTZRFJGC-UHFFFAOYSA-N 2-ethylpropanediamide Chemical compound CCC(C(N)=O)C(N)=O JPTLLABTZRFJGC-UHFFFAOYSA-N 0.000 description 2
- CGRKYGKHZOCPSZ-UHFFFAOYSA-N 2-methylpropanediamide Chemical compound NC(=O)C(C)C(N)=O CGRKYGKHZOCPSZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000002608 ionic liquid Substances 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- -1 nitrogen halide Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000007539 photo-oxidation reaction Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- YWUIUNGMQOICND-UHFFFAOYSA-N (2z)-2-diazo-1,1,1-trifluoroethane Chemical compound FC(F)(F)C=[N+]=[N-] YWUIUNGMQOICND-UHFFFAOYSA-N 0.000 description 1
- YKYIFUROKBDHCY-UHFFFAOYSA-N 4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical compound CCOC=CC(=O)C(F)(F)F YKYIFUROKBDHCY-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- MLIREBYILWEBDM-UHFFFAOYSA-N anhydrous cyanoacetic acid Natural products OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- LIAWOTKNAVAKCX-UHFFFAOYSA-N hydrazine;dihydrochloride Chemical compound Cl.Cl.NN LIAWOTKNAVAKCX-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- FNEQSJOUOUGPBG-UHFFFAOYSA-N pyrimidin-2-yl dihydrogen phosphate Chemical compound OP(O)(=O)OC1=NC=CC=N1 FNEQSJOUOUGPBG-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
【解決手段】下記式で表される環式化合物を製造する方法であって、(a)式R1−C(O)−X(Xはハロゲン)の酸ハロゲン化物をCH2=CH−OR2(II)(R2はアルキル基、アラルキル基又はアリール基)のビニルエーテルに付加して、付加生成物を生成する工程と、(b)前記付加生成物をY−A−Z(III)の化合物と反応させる工程と、を含む方法。
[R1はハロゲン化アルキル基;Z及びYは各々独立に炭素又はヘテロ原子;Aは環において0、1、2又は3個の原子を含む、ZとYの間の結合基]
【選択図】なし
Description
ZおよびYは独立して、炭素またはヘテロ原子を表し、
Aは、環において0、1、2または3個の原子を含む、ZとYの間の結合基である)
の環式化合物を製造する方法であって、
(a)式R1−C(O)−X(X=フッ素、塩素または臭素であり、R1は上記で示される意味を有する)の酸ハロゲン化物を式(II)CH2=CH−OR2(II)(R2はアルキル基、アラルキル基またはアリール基である)のビニルエーテルに付加して、付加生成物を生成する工程と、(b)前記付加生成物を式(III)Y−A−Z(III)(Z、YおよびAは上記で定義されるとおりである)の化合物と反応させる工程と、を含む方法に関する。
のうちの1つに相当する、本発明の式(I)の化合物の製造に適切に用いられる。後者の場合、Aは適切には、−CH2−、−C(=O)−、−CH2−CH2およびCH2−C(=O)−および−C(=S)−から選択され、R3はHまたはC1〜C6アルキルである。
ZおよびYは独立して、炭素またはヘテロ原子を表し、
Aは、環において0、1、2または3個の原子を含む、ZとYの間の結合基である)の環式化合物を合成する方法であって、
式R1−C(O)−X(X=フッ素、塩素または臭素であり、R1は上記で示される意味を有する)の酸ハロゲン化物を式(II)CH2=CH−OR2(II)(R2は、アルキル基、アラルキル基またはアリール基である)のビニルエーテルに付加することによって得られる付加生成物を、ハロゲン化水素、特に塩化水素の存在下にて、式(III)Y−A−Z(III)(Z、YおよびAは上記で定義されるとおりである)の化合物と反応させる、方法にも関する。
6−(トリフルオロメチル)ピリミジン−2(1H)−オンの製造
トリフルオロアセチルクロリドをエチルビニルエーテルに付加することによって製造された、等モル量の4−エトキシ−1,1,1−トリフルオロ−3−ブテン−2−オン(ETFBO)を、機械攪拌機、還流冷却器および滴下漏斗を備えた三つ口フラスコにおけるメタノール2.2L中の尿素8.74モルの溶液に、N2雰囲気下にて約3時間にわたって、一滴ずつ添加した。反応混合物の温度を15℃未満に維持した。15分後、濃HCl溶液(32%)1.35Lを得られた冷却懸濁液に添加し、透明な溶液が得られた。その溶液をゆっくりと60℃に加熱し、2時間攪拌した後、懸濁液が形成した。60℃で一晩攪拌し、続いて0〜5℃で1時間攪拌した後、沈殿物を濾過除去した。pHが中性になるまで、残留物を水で洗浄し、続いてヘキサン(約500ml)で洗浄した。減圧下にて2Lフラスコ中で回転蒸発器にて一晩乾燥させた後、6−(トリフルオロメチル)ピリミジン−2(1H)−オンが無色の結晶として得られた。収量は1.2kgであった(理論収量85%)。
3−(トリフルオロメチル)1H−ピラゾールの製造
トリフルオロアセチルクロリドをエチルビニルエーテルに付加することによって製造された、等モル量のETFBOを、機械攪拌機、還流冷却器および滴下漏斗を備えた三つ口フラスコにおけるメタノール2.2L中のヒドラジン塩酸塩4.4モルの溶液に、N2雰囲気下にて約4時間にわたって、一滴ずつ添加した。反応混合物の温度を15℃未満に維持した。12時間還流した後、反応バッチを2Lフラスコにおいて濾過し、真空下で濃縮した(同一バッチが同一条件下で製造され、どちらの粗生成物の収率も約95%であった)。続いて、27ミリバールでショートパス真空蒸留によって、合わせた粗生成物を精製した。収量は1105gであり、理論収量92%に相当する。
CETFBOからの6−(トリフルオロメチル)ピリミジン−2(1H)−オンの製造
CETFBOの合成:約−30℃で約2時間冷却された三つ口フラスコ中で、トリフルオロアセチルクロリド4.0モルを濃縮した。−30℃で約2.5時間冷却された液体トリフルオロアセチルクロリドに、エチルビニルエーテル4.0モルを一滴ずつ添加した。HClを除去することなく、CETFBOが定量的に得られた。
3−ピリジンカルボン酸,1,2−ジヒドロ−2−オキソ−6−(トリフルオロメチル)−メチルエステル(MTFPMOC)の製造
約20分間にわたって激しく攪拌しながら、メチルマロンアミド(MMA)420ミリモルを氷冷トリエチルアミン(420ミリモル)に添加した。次いで、エチルビニルエーテルにTFACを付加することによって製造されたETFBOを、氷冷下にて約30分間にわたって一滴ずつ添加し、反応混合物の温度を10℃未満に維持した。次いで、反応混合物をさらに室温で20時間攪拌した。pHが3になるまで、その溶液に濃HCl溶液(2N)を添加した。溶液を酢酸エチルで抽出した後、有機相を水で洗浄し、硫酸ナトリウムで乾燥させた。回転蒸発器で揮発性化合物を除去した後、粗生成物が収率86%で得られた。メタノール/水から結晶化した後、MTFPMOCが純度>98%(GC)で得られた。
3−ピリジンカルボン酸,1,2−ジヒドロ−2−オキソ−6−(トリフルオロメチル)−エチルエステル(ETFPMOC)の製造
約20分間にわたって激しく攪拌しながら、エチルマロンアミド(EMA)420ミリモルを氷冷トリエチルアミン(420ミリモル)に添加した。次いで、エチルビニルエーテルにTFACを付加することによって製造されたETFBOを、氷冷下にて約30分間にわたって一滴ずつ添加し、反応混合物の温度を10℃未満に維持した。次いで、反応混合物をさらに室温で20時間攪拌した。pHが3になるまで、その溶液に濃HCl溶液(2N)を添加した。溶液を酢酸エチルで抽出した後、有機相を水で洗浄し、硫酸ナトリウムで乾燥させた。回転蒸発器で揮発性化合物を除去した後、粗生成物が収率86%で得られた。メタノール/水から結晶化した後、ETFPMOCが純度>98%(GC)で得られた。
Claims (17)
- 式(I):
ZおよびYは独立して、炭素またはヘテロ原子を表し
Aは、環において0、1、2または3個の原子を含む、ZとYの間の結合基である)
の環式化合物を製造する方法であって、
(a)式R1−C(O)−X(X=フッ素、塩素または臭素であり、R1は上記で示される意味を有する)の酸ハロゲン化物を式(II)CH2=CH−OR2(II)(R2はアルキル基、アラルキル基またはアリール基である)のビニルエーテルに付加して、付加生成物を生成する工程と、
(b)前記付加生成物を式(III)Y−A−Z(III)(Z、YおよびAは上記で定義されるとおりである)の化合物と反応させる工程と、
を含む方法。 - R1が、CF3、CF2HおよびCF2Clから好ましくは選択されるC1〜C3ハロゲン化アルキル基である、請求項1に記載の方法。
- R2が、C1〜C4アルキル基、好ましくはエチル基である、請求項1から6のいずれか一項に記載の方法。
- ZおよびYが独立して、酸素、硫黄、窒素および炭素から選択される、請求項1から7のいずれか一項に記載の方法。
- ZおよびYのうちの少なくとも1つが窒素である、請求項8に記載の方法。
- Aが、1または2個のカテナリー炭素原子を含む、請求項1から9のいずれか一項に記載の方法。
- 式(III)の前記化合物が、ヒドラジンまたはその含水化合物または塩酸塩、尿素、チオ尿素、マロン酸モノアミドおよびマロモノニトリルから選択される、請求項1から10のいずれか一項に記載の方法。
- 工程(a)で生成されたHXが、工程(b)に供給される、請求項1から12のいずれか一項に記載の方法。
- 工程(b)に供給された前記付加生成物が、工程(a)からの粗生成物である、請求項1から13のいずれか一項に記載の方法。
- 工程(b)の前記反応が、範囲−15℃〜+80℃の温度で行われる、請求項1から14のいずれか一項に記載の方法。
- 固液分離または蒸留によって、工程(b)の前記反応媒体から式(I)の前記化合物を単離することをさらに含む、請求項1から15のいずれか一項に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08165547.4 | 2008-09-30 | ||
EP08165547 | 2008-09-30 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015125708A Division JP6511346B2 (ja) | 2008-09-30 | 2015-06-23 | ハロゲン化環式化合物の合成方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019186868A Division JP2020023533A (ja) | 2008-09-30 | 2019-10-10 | ハロゲン化環式化合物の合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018058869A true JP2018058869A (ja) | 2018-04-12 |
JP6647268B2 JP6647268B2 (ja) | 2020-02-14 |
Family
ID=40351699
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011529509A Active JP6180705B2 (ja) | 2008-09-30 | 2009-09-25 | ハロゲン化環式化合物の合成方法 |
JP2015125708A Active JP6511346B2 (ja) | 2008-09-30 | 2015-06-23 | ハロゲン化環式化合物の合成方法 |
JP2017225725A Active JP6647268B2 (ja) | 2008-09-30 | 2017-11-24 | ハロゲン化環式化合物の合成方法 |
JP2019186868A Pending JP2020023533A (ja) | 2008-09-30 | 2019-10-10 | ハロゲン化環式化合物の合成方法 |
JP2021184880A Pending JP2022028792A (ja) | 2008-09-30 | 2021-11-12 | ハロゲン化環式化合物の合成方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011529509A Active JP6180705B2 (ja) | 2008-09-30 | 2009-09-25 | ハロゲン化環式化合物の合成方法 |
JP2015125708A Active JP6511346B2 (ja) | 2008-09-30 | 2015-06-23 | ハロゲン化環式化合物の合成方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019186868A Pending JP2020023533A (ja) | 2008-09-30 | 2019-10-10 | ハロゲン化環式化合物の合成方法 |
JP2021184880A Pending JP2022028792A (ja) | 2008-09-30 | 2021-11-12 | ハロゲン化環式化合物の合成方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US8431710B2 (ja) |
EP (1) | EP2334645B1 (ja) |
JP (5) | JP6180705B2 (ja) |
KR (3) | KR20160131129A (ja) |
CN (2) | CN102164898A (ja) |
CA (1) | CA2735921C (ja) |
WO (1) | WO2010037688A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101652539B1 (ko) | 2008-07-04 | 2016-08-30 | 솔베이(소시에떼아노님) | 알케논의 제조 방법 |
EP2334645B1 (en) | 2008-09-30 | 2019-11-06 | Solvay Sa | Process for the synthesis of fluorinated cyclic compounds |
GB0903749D0 (en) * | 2009-03-04 | 2009-04-15 | Syngenta Participations Ag | Chemical process |
US8957254B2 (en) | 2009-07-06 | 2015-02-17 | Solvay Sa | Process for chemical synthesis from an alkenone made from a halogenated precursor |
EP2451763B1 (en) | 2009-07-06 | 2015-03-04 | Solvay Sa | Process for the manufacture of halogenated precursors of alkenones in the presence of a solvent |
EP2662359A1 (en) | 2012-05-08 | 2013-11-13 | Solvay Sa | Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same |
JP6426090B2 (ja) * | 2012-08-22 | 2018-11-21 | ソルヴェイ(ソシエテ アノニム) | アルケノンの製造方法 |
WO2014096284A1 (en) | 2012-12-20 | 2014-06-26 | Solvay Sa | Salts of n-containing heterocyclic anions as components in electrolytes |
MX2015017640A (es) * | 2013-06-20 | 2016-09-07 | Basf Se | Proceso para preparar compuestos de piridilpirazol y sus derivados de piridilhidrazina. |
EP2987782A1 (en) | 2014-08-22 | 2016-02-24 | Solvay SA | Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide |
WO2016079122A1 (en) | 2014-11-17 | 2016-05-26 | Solvay Sa | A method for producing a chemical compound and apparatus therefor |
CN107001231A (zh) | 2014-11-17 | 2017-08-01 | 索尔维公司 | 包括至少两个蒸馏步骤以获得纯化的卤化的羧酸卤化物的蒸馏方法、以及该纯化的卤化的羧酸卤化物的用途 |
EP3031791A1 (en) | 2014-12-10 | 2016-06-15 | Solvay SA | Halogenation process of 1,1-dihaloethene |
EP3199522A1 (en) | 2016-02-01 | 2017-08-02 | Solvay SA | Aminothioate derivatives, production thereof and use |
CN111372908A (zh) | 2017-09-04 | 2020-07-03 | 索尔维公司 | 用于制造二氟乙酰氯的方法和中间体 |
WO2020093715A1 (en) | 2018-11-07 | 2020-05-14 | Fujian Yongjing Technology Co., Ltd | New process for manufacture of pyrazoles or pyrimidones |
JP2023512000A (ja) | 2020-01-31 | 2023-03-23 | ソルヴェイ(ソシエテ アノニム) | ハロアルキル置換ピリジン化合物の製造のプロセス |
JP2021079146A (ja) * | 2021-02-22 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
JP7315071B2 (ja) * | 2021-03-03 | 2023-07-26 | 株式会社三洋物産 | 遊技機 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163280A1 (de) * | 1984-05-30 | 1985-12-04 | BASF Aktiengesellschaft | Pyrimidylphosphorsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen |
EP0522392A1 (en) * | 1991-07-11 | 1993-01-13 | E.I. Du Pont De Nemours And Company | Substituted pyridines and a process for their preparation |
JPH06505489A (ja) * | 1991-03-07 | 1994-06-23 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | 除草性ピリジンスルホンアミド |
GB2305174A (en) * | 1995-09-15 | 1997-04-02 | Zeneca Ltd | Chemical process |
JPH09132554A (ja) * | 1995-08-08 | 1997-05-20 | Ishihara Sangyo Kaisha Ltd | 4−アルコキシ−1,1,1−トリフルオロ−3−ブテン−2−オンの製造方法 |
JP2002501516A (ja) * | 1997-05-29 | 2002-01-15 | メルク シヤープ エンド ドーム リミテツド | スピロアザシクロ誘導体および治療薬としての該誘導体の使用 |
WO2006058201A2 (en) * | 2004-11-23 | 2006-06-01 | Reddy Us Therapeutics, Inc. | Heterocyclic and bicyclic compounds, compositions and methods |
WO2007088876A1 (ja) * | 2006-02-02 | 2007-08-09 | Kumiai Chemical Industry Co., Ltd. | ピリドン誘導体及び除草剤 |
WO2008098239A2 (en) * | 2007-02-09 | 2008-08-14 | Emory University | Paramyxovirus family inhibitors and methods of use thereof |
JP2011526899A (ja) * | 2008-07-01 | 2011-10-20 | ダウ アグロサイエンシィズ エルエルシー | 2−トリフルオロメチル−5−(1−置換)アルキルピリジンの調製のための改善された方法 |
JP2015227339A (ja) * | 2008-09-30 | 2015-12-17 | ソルヴェイ(ソシエテ アノニム) | ハロゲン化環式化合物の合成方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4128828A1 (de) | 1991-08-30 | 1993-03-04 | Basf Ag | Ammonium- oder harnstoffhaltige duengemittel und verfahren zu ihrer herstellung |
US5708174A (en) * | 1992-03-12 | 1998-01-13 | Smithkline Beecham P.L.C. | Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
ES2119952T3 (es) | 1993-12-23 | 1998-10-16 | Solvay Fluor & Derivate | Procedimiento para la preparacion de cloruros de acidos polifluoroclorocarboxilicos y perfluorocarboxilicos bajo adicion de cloro. |
DE19821088A1 (de) | 1998-05-12 | 1999-11-18 | Basf Ag | Modifizierte Polykondensate der Asparaginsäure, Verfahren zu ihrer Herstellung und ihre Verwendung in Düngemitteln |
WO2002053518A2 (en) | 2000-12-29 | 2002-07-11 | Honeywell International, Inc. | HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS |
PT1601653E (pt) | 2003-03-07 | 2009-04-27 | Syngenta Participations Ag | Processo para a produção de ésteres de ácido nicotínico substituído |
DE10325715A1 (de) * | 2003-06-06 | 2004-12-23 | Solvay Fluor Und Derivate Gmbh | Vereinfachte Herstellung von Alkenonen |
DE102004061593A1 (de) | 2004-12-21 | 2006-06-22 | Abbott Gmbh & Co. Kg | Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung |
EP1940842B1 (en) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
EP1987717A1 (de) * | 2007-04-30 | 2008-11-05 | Bayer CropScience AG | Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung |
EP2008996A1 (en) * | 2007-06-27 | 2008-12-31 | Syngeta Participations AG | Process for the production of pyrazoles |
KR101652539B1 (ko) | 2008-07-04 | 2016-08-30 | 솔베이(소시에떼아노님) | 알케논의 제조 방법 |
EP2154167A1 (de) * | 2008-07-30 | 2010-02-17 | Bayer MaterialScience AG | Elektromechanischer Wandler mit einem Polymerelement auf Polyisocyanat-Basis |
KR101782175B1 (ko) | 2009-07-06 | 2017-09-26 | 솔베이(소시에떼아노님) | 알케논의 제조 방법 |
EP2451763B1 (en) | 2009-07-06 | 2015-03-04 | Solvay Sa | Process for the manufacture of halogenated precursors of alkenones in the presence of a solvent |
PT2451765T (pt) | 2009-07-06 | 2017-04-03 | Solvay | Processo para o fabrico de precursores halogenados de alquenonas sob condições específicas |
JP6194245B2 (ja) * | 2013-12-27 | 2017-09-06 | 株式会社Subaru | 信号機認識装置 |
-
2009
- 2009-09-25 EP EP09783436.0A patent/EP2334645B1/en active Active
- 2009-09-25 KR KR1020167031136A patent/KR20160131129A/ko active Search and Examination
- 2009-09-25 CN CN2009801384364A patent/CN102164898A/zh active Pending
- 2009-09-25 JP JP2011529509A patent/JP6180705B2/ja active Active
- 2009-09-25 KR KR1020197018768A patent/KR20190080972A/ko not_active Application Discontinuation
- 2009-09-25 KR KR1020117009786A patent/KR20110066201A/ko active Search and Examination
- 2009-09-25 WO PCT/EP2009/062462 patent/WO2010037688A1/en active Application Filing
- 2009-09-25 US US13/120,505 patent/US8431710B2/en not_active Expired - Fee Related
- 2009-09-25 CN CN201610380671.4A patent/CN106083710B/zh active Active
- 2009-09-25 CA CA2735921A patent/CA2735921C/en not_active Expired - Fee Related
-
2013
- 2013-04-29 US US13/872,860 patent/US8981115B2/en not_active Expired - Fee Related
-
2015
- 2015-06-23 JP JP2015125708A patent/JP6511346B2/ja active Active
-
2017
- 2017-11-24 JP JP2017225725A patent/JP6647268B2/ja active Active
-
2019
- 2019-10-10 JP JP2019186868A patent/JP2020023533A/ja active Pending
-
2021
- 2021-11-12 JP JP2021184880A patent/JP2022028792A/ja active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163280A1 (de) * | 1984-05-30 | 1985-12-04 | BASF Aktiengesellschaft | Pyrimidylphosphorsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen |
JPH06505489A (ja) * | 1991-03-07 | 1994-06-23 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | 除草性ピリジンスルホンアミド |
EP0522392A1 (en) * | 1991-07-11 | 1993-01-13 | E.I. Du Pont De Nemours And Company | Substituted pyridines and a process for their preparation |
JPH09132554A (ja) * | 1995-08-08 | 1997-05-20 | Ishihara Sangyo Kaisha Ltd | 4−アルコキシ−1,1,1−トリフルオロ−3−ブテン−2−オンの製造方法 |
GB2305174A (en) * | 1995-09-15 | 1997-04-02 | Zeneca Ltd | Chemical process |
JP2002501516A (ja) * | 1997-05-29 | 2002-01-15 | メルク シヤープ エンド ドーム リミテツド | スピロアザシクロ誘導体および治療薬としての該誘導体の使用 |
WO2006058201A2 (en) * | 2004-11-23 | 2006-06-01 | Reddy Us Therapeutics, Inc. | Heterocyclic and bicyclic compounds, compositions and methods |
WO2007088876A1 (ja) * | 2006-02-02 | 2007-08-09 | Kumiai Chemical Industry Co., Ltd. | ピリドン誘導体及び除草剤 |
WO2008098239A2 (en) * | 2007-02-09 | 2008-08-14 | Emory University | Paramyxovirus family inhibitors and methods of use thereof |
JP2011526899A (ja) * | 2008-07-01 | 2011-10-20 | ダウ アグロサイエンシィズ エルエルシー | 2−トリフルオロメチル−5−(1−置換)アルキルピリジンの調製のための改善された方法 |
JP2015227339A (ja) * | 2008-09-30 | 2015-12-17 | ソルヴェイ(ソシエテ アノニム) | ハロゲン化環式化合物の合成方法 |
JP6180705B2 (ja) * | 2008-09-30 | 2017-08-16 | ソルヴェイ(ソシエテ アノニム) | ハロゲン化環式化合物の合成方法 |
Non-Patent Citations (6)
Title |
---|
CHEMISCHE BERICHTE, vol. Vol.115(8), JPN6014001963, 1982, pages 2766 - 2782, ISSN: 0004048152 * |
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, vol. Iss.17, JPN6014001965, 2002, pages 2913 - 2920, ISSN: 0004048153 * |
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, vol. Iss.17, JPN6014001971, 2004, pages 3714 - 3718, ISSN: 0004048155 * |
SYNTHESIS, JPN6014001955, 2000, pages 738 - 742, ISSN: 0004048150 * |
SYNTHESIS, JPN6014001959, 1991, pages 483 - 486, ISSN: 0004048151 * |
TETRAHEDRON LETTERS, vol. Vol.39(43), JPN6014001968, 1998, pages 7965 - 7966, ISSN: 0004048154 * |
Also Published As
Publication number | Publication date |
---|---|
US8431710B2 (en) | 2013-04-30 |
JP6647268B2 (ja) | 2020-02-14 |
KR20160131129A (ko) | 2016-11-15 |
US20110178297A1 (en) | 2011-07-21 |
CA2735921C (en) | 2017-03-21 |
CN102164898A (zh) | 2011-08-24 |
US20130237710A1 (en) | 2013-09-12 |
WO2010037688A1 (en) | 2010-04-08 |
JP2012504153A (ja) | 2012-02-16 |
EP2334645A1 (en) | 2011-06-22 |
JP6511346B2 (ja) | 2019-05-15 |
JP2022028792A (ja) | 2022-02-16 |
CN106083710B (zh) | 2021-03-12 |
KR20110066201A (ko) | 2011-06-16 |
CA2735921A1 (en) | 2010-04-08 |
JP2015227339A (ja) | 2015-12-17 |
KR20190080972A (ko) | 2019-07-08 |
EP2334645B1 (en) | 2019-11-06 |
US8981115B2 (en) | 2015-03-17 |
JP2020023533A (ja) | 2020-02-13 |
CN106083710A (zh) | 2016-11-09 |
JP6180705B2 (ja) | 2017-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6180705B2 (ja) | ハロゲン化環式化合物の合成方法 | |
JP5608221B2 (ja) | [4−(2−クロロ−4−メトキシ−5−メチルフェニル)−5−メチル−チアゾロ−2−イル]−[2−シクロプロピル−1−(3−フルオロ−4−メチルフェニル)−エチル]−アミンを調製するための方法 | |
WO2018184196A1 (zh) | 一种制备2-芳基丙二酰胺的方法及其应用 | |
KR102079116B1 (ko) | 4-할로알킬-3-머캅토-치환된 2-하이드록시벤조산 유도체의 제조방법 | |
US6320053B1 (en) | Preparation of heteroarylcarboxamides | |
EP0899262B1 (en) | Process for the preparation of heteroarylcarboxylic amides and esters | |
JP4879907B2 (ja) | フェニル2−ピリミジニルケトン類の製造方法及びその新規中間体 | |
JP2991832B2 (ja) | ピリミジン誘導体の製造方法 | |
JP4345095B2 (ja) | 銅塩を用いるアミド化合物の高選択的o−アルキル化方法 | |
JP6466107B2 (ja) | 4−フェニルチオ−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 | |
JP4032861B2 (ja) | β−オキソニトリル誘導体又はそのアルカリ金属塩の製法 | |
WO2003014067A1 (en) | PROCESS FOR PRODUCING ß-OXONITRILE COMPOUND OR ALKALI METAL SALT THEREOF | |
JP3085513B2 (ja) | 5−クロロ−4−ヒドロキシ−6−メチルピリミジンの製法 | |
JP4663105B2 (ja) | 2−スルホニル−4−オキシピリジン誘導体の製造方法 | |
JP6466109B2 (ja) | 2−ベンジルオキシ−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 | |
JP2014514298A (ja) | N−アルキル−n−トリアルキルシリルアミド類の工業的調製方法 | |
JP2009046401A (ja) | ヒドラジン化合物の製造方法およびその製造中間体 | |
JPH1077270A (ja) | 2−(1−クロロビニル)ピリジン誘導体およびその製造方法 | |
JP2000344755A (ja) | 2−アミジノピリミジン類の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180702 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181002 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181227 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190610 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191010 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20191021 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191216 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200114 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6647268 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |